Al-Arabiya for Medical Solutions and Medicines
APICO is still being established, while aiming at setting up a factory for intravenous solutions in addition to producing and marketing all kinds of intravenous solutions. APICO's vision is in concordance with the strategy, objectives and goals of ACDIMA represented in supporting the pharmaceutical industry in the Arab World while concentrating on diversification and covering all therapeutic categories and segments. APICO's capital is LYD 1 million, of which ACDIMA owns 49%.
The Company's products and production capacity
Production of Intravenous medications (I.V) and medication with the best international technology .
Cover and provide for the needs of the local market of the medication that is targeted for production.
Considering the possibility of running local factories through contracted production
To begin active producing through contracted production in specialized global-quality factories as a first stage.